Perioperative coagulation management during cardiac surgery

Current Opinion in Anaesthesiology

Volumn 26, Issue 1, 2013, Pages 60-64

  Weber, Christian F ^a   Klages, Matthias ^a   Zacharowski, Kai ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Cardiac surgery; Coagulation management; Coagulopathy; Hemostasis; Point of care coagulation testing

Indexed keywords

ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEPARIN; PROTAMINE; PROTHROMBIN; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ALGORITHM; ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOTTING DISORDER; COST CONTROL; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; RECOMMENDED DRUG DOSE; REVIEW; SURGICAL RISK; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOELASTOGRAPHY; VISCOELASTICITY;

BLOOD COAGULATION; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; HUMANS; INTRAOPERATIVE CARE; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; POINT-OF-CARE SYSTEMS;

EID: 84872180269     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32835afd28     Document Type: Review

References (31)

1. Vivacqua A, Koch CG, Yousuf AM. Morbidity of bleeding after cardiac surgery: Is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg 2011; 91:1780-L790.
2. Murphy GJ, Reeves BC, Rogers CA. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116:2544-2552. (Pubitemid 350179219)
3. Avidan MS, Alcock EL, Da Fonseca J. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92:178-L86.
4. Ickx BE, Faraoni D. Management of the clotting system: A European perspective. Curr Opin Anaesthesiol 2012; 25:80-85.
5. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007; 73:401-415. (Pubitemid 47249577)
6. Toulon P, Ozier Y, Ankri A. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009; 101:394-401.
7. Haas T, Spielmann N, Mauch J. Comparison of thromboelastometry (ROTEM(R)) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108:36-41.
8. Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med 1951; 117:189-203.
9. Shore-Lesserson L, Manspeizer HE, DePerio M. Thromboelastographyguided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88:312-319. (Pubitemid 29070189)
10. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86:575-578. (Pubitemid 32266324)
11. Nuttall GA, Oliver WC, Santrach PJ. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94:773-781; discussion 775A-776A. (Pubitemid 32429746)
12. Ak K, Isbir CS, Tetik S. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg 2009; 24:404-410.
13. Westbrook AJ, Olsen J, Bailey M. Protocol based on thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: A pilot study. Heart Lung Circ 2009; 18:277-288.
14. Weber CF, Görlinger K, Meininger D. Point-of-care testing: A Prospective, Randomized Clinical Trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117:531-547.
15. Gorlinger K, Dirkmann D, Hanke AA. First-line Therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A Retrospective, Single-center Cohort Study. Anesthesiology 2011; 115: 1179-L191.
16. Lier H, Krep H, Schroeder S. Preconditions of hemostasis in trauma: A review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65:951-960.
17. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81:360-365.
18. Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113:1205-L219.
19. Sarani B, Dunkman WJ, Dean L. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008; 36:1114-L118.
20. Watson GA, Sperry JL, Rosengart MR. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67:221-227; discussion 228-230.
21. Warmuth M, Mad P, Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta Anaesthesiol Scand 2012; 56:539-548.
22. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009; 102:345-354.
23. Scharbert G, Kalb M, Marschalek C. The effects of test temperature and storage temperature on platelet aggregation: A whole blood in vitro study. Anesth Analg 2006; 102:1280-L284.
24. Rinder CS, Bohnert J, Rinder HM. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991; 75:388-393.
25. Rinder CS, Mathew JP, Rinder HM. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991; 75:563-570.
26. Weber CF, Dietrich W, Spannagl M. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode wholeblood aggregometry in patients after cardiac surgery. Anesth Analg 2010; 110:702-707.
27. Lethagen S. Desmopressin (DDAVP) and hemostasis. Ann Hematol 1994; 69:173-L80.
28. Wang SC, Shieh JF, Chang KY. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: Randomized clinical trial. Transplant Proc 2010; 42:2590-2593.
29. Rothwell SW, Maglasang P, Krishnamurti C. Survival of fresh human platelets in a rabbit model as traced by flow cytometry. Transfusion 1998; 38:550-556. (Pubitemid 28317230)
30. Cauwenberghs S, van Pampus E, Curvers J. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 2007; 21:287-294. (Pubitemid 47444515)
31. Yank V, Tuohy CV, Logan AC. Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011; 154:529-540.